The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.Ann Intern Med. 2020 Oct 20; 173(8):662-663.AIM
Abstract
In their article, Skipper and colleagues report the results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19. The editorialists discuss the findings and the need to examine carefully not only what we know about hydroxychloroquine and COVID-19 but also how we learned it, disseminated it, and put it into practice.
Links
MeSH
Pub Type(s)
Editorial
Language
eng
PubMed ID
32673059
Citation
Schluger, Neil W.. "The Saga of Hydroxychloroquine and COVID-19: a Cautionary Tale." Annals of Internal Medicine, vol. 173, no. 8, 2020, pp. 662-663.
Schluger NW. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Ann Intern Med. 2020;173(8):662-663.
Schluger, N. W. (2020). The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Annals of Internal Medicine, 173(8), 662-663. https://doi.org/10.7326/M20-5041
Schluger NW. The Saga of Hydroxychloroquine and COVID-19: a Cautionary Tale. Ann Intern Med. 2020 Oct 20;173(8):662-663. PubMed PMID: 32673059.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
A1 - Schluger,Neil W,
Y1 - 2020/07/16/
PY - 2020/7/17/pubmed
PY - 2020/10/28/medline
PY - 2020/7/17/entrez
SP - 662
EP - 663
JF - Annals of internal medicine
JO - Ann Intern Med
VL - 173
IS - 8
N2 - In their article, Skipper and colleagues report the results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19. The editorialists discuss the findings and the need to examine carefully not only what we know about hydroxychloroquine and COVID-19 but also how we learned it, disseminated it, and put it into practice.
SN - 1539-3704
UR - https://www.unboundmedicine.com/medline/citation/32673059/The_Saga_of_Hydroxychloroquine_and_COVID_19:_A_Cautionary_Tale_
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
